However, the stock’s recent share gains have pushed the price up to $388.65, leaving room for just 2% upside before hitting the $396.88 average price target. Terms of Use and Privacy Policy. As such, CRSP is trading 3.91% off suggested target … In depth view into CRISPR Therapeutics Price Target Upside (Daily) including historical data from 2016, charts, stats and industry comps. Crispr's third-quarter business update highlighted progress across the company's pipeline, including … CRISPR Therapeutics AG (NASDAQ:CRSP) trade information The consensus price target for the stock as assigned by Wall Street analysts is $137.63, meaning bulls need a downside of … View CRISPR Therapeutics AG CRSP investment & stock information. CRISPR Therapeutics AG analyst ratings, historical stock prices, earnings estimates & actuals. Get the latest CRISPR Therapeutics AG CRSP detailed stock quotes, stock data, Real-Time ECN, charts, stats … On January 12, 2021 "Truist" gave "" rating for CRSP. The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Start Your Risk-Free Trial Subscription Here, 3 Clean Energy Stocks that Could Get Boosted by Biden, Mine OK'd in Trump's last days may boost Biden energy plan, Insurers add food to coverage menu as way to improve health, DuPont, Chemours reach agreement over 'forever chemicals', The Latest: Short on bed space, Brazilian state locks down, One of 22 workers trapped in China gold mine rescued, Why These 3 ETFs Should be in Your 2021 Portfolio, Buy Kinder Morgan, Inc While It Still Yields 6.75%. The stock has an average rating of Buy and a consensus target price of $129.00. ET by Tomi Kilgore Crisper Therapeutics shares decline on wider-than-expected loss document.write(''); While the media is focusing on Elon Musk’s rocket launch… My Portfolio. Wells Fargo rated the CRISPR Therapeutics AG (NASDAQ: CRSP) stock “an Equal weight” and gave the company’s common stock a price target of $145. The … Wells Fargo’s estimates were … In predicting price targets of as low as $45 and as high as $210, analysts are in agreement on assigning the stock over the next 12 months average price target of $146.56. Man Who Predicted March 2020 Crash Makes Bold Tech Stock Prediction. We are all together in this COVID-19 pandemic. Learn more. But CRISPR Stock Remains a Buy Yahoo 11/20 09:17 ET. Please log in to your account or sign up in order to add this asset to your watchlist. View which stocks are hot on social media with MarketBeat's trending stocks report. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Receive a free world-class investing education from MarketBeat. View CRISPR Therapeutics AG CRSP investment & stock information. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). All stock picks. The price target was set to $170.00 → $210.00. Real-time data provided for free by IEX. See what's happening in the market right now with MarketBeat's real-time news feed. Portfolios. Down 28.5% In 24 Hours, Where Does Ethereum (ETH) Go From Here? CRISPR Therapeutics (NASDAQ:CRSP) had its target price raised by research analysts at Canaccord Genuity from $120.00 to $151.00 in a research note issued to investors on Monday, The Fly reports. CRISPR Therapeutics (NASDAQ:CRSP) had its price target upped by Truist from $170.00 to $210.00 in a research note issued to investors on Tuesday, The Fly reports. Based on 17 analysts offering 12 month price targets for Crispr Therapeutics AG in the last 3 months. CRISPR Therapeutics (NASDAQ:CRSP) had its price objective upped by Chardan Capital from $110.00 to $166.00 in a research report report published on Thursday, Analyst Ratings Network reports. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. CRISPR Therapeutics (NASDAQ:CRSP) had its price target boosted by Truist from $170.00 to $210.00 in a research report released on Tuesday, The Fly reports. All rights reserved. View Analyst Price Targets for Crispr Therapeutics. Learn more. They now have a $145.00 price … This price target is based on 16 analysts offering 12 month price targets for CRISPR Therapeutics in the last 3 months. The business has a fifty day simple … In other news, Director Bradley J. Phd Bolzon sold 171,004 shares of the company’s stock in … Given the current short-term trend, the stock is expected to rise 115.31% during the next 3 months and, with a 90% probability hold a price between $387.80 and $473.00 at the end of this 3-month period. The stock traded as high as $185.03 and last traded at $185.03, with a volume of 15682 … The average price target is $141.79, with a high forecast of … featured in The Global Fintech Index 2020 as the top Fintech company of the country. Export data to Excel for your own analysis. View today's stock price, news and analysis for CRISPR Therapeutics AG (CRSP). Average Target Price: 144.06: Number Of Ratings: 19: FY Report Date: 12/2020: Last Quarter's Earnings-1.32: Year Ago Earnings: 0.01: Current Quarter's Estimate-1.27: Current Year's … Find the latest CRISPR Therapeutics AG (CRSP) stock quote, history, news and other vital information to help you with your stock trading and investing. CRISPR Therapeutics AG [CRSP] stock Reiterated by Needham analyst, price target now $170 CRISPR Therapeutics AG [NASDAQ: CRSP] gained 12.27% on the last trading session, … Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. View today's stock price, news and analysis for CRISPR Therapeutics AG (CRSP). Elon Musk Makes Shocking Bet On New Tech? Of Politics and Stock Prices Jan 17 / MotleyFool.com - Paid Partner Content The Zacks Analyst Blog Highlights: CRISPR Therapeutics, Vertex Pharmaceuticals and Intellia Therapeutics In a report released today, Alan Carr from Needham assigned a Buy rating to Crispr Therapeutics AG (CRSP – Research Report), with a price target of $170.00.The company’s shares … Mean consensus: OUTPERFORM: Number of Analysts: 18: Average target price: 137,63 $ Last Close Price: 148,61 $ Spread / Highest target: 21,1%: Spread / Average Target … Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. In this daily Point and Figure chart of CRSP, below, we can see a price target of $200. Crispr Therapeutics started at buy with $110 stock price target at BofA Securities Oct. 5, 2020 at 11:33 a.m. CRISPR Therapeutics AG quote is equal to 198.240 USD at 2021-01-20. Their average twelve-month price target is $141.79, predicting that the stock has … 16 Wall Street analysts have issued ratings and price targets for CRISPR Therapeutics in the last 12 months. On October 22, 2020 "Chardan Capital" gave "Positive - Buy" rating for CRSP. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. The average price target is $146.07 with a high forecast of $210.00 and a low forecast of $45.00. This suggests a possible upside of 27.2% from the stock's current price. Wells Fargo rated the CRISPR Therapeutics AG (NASDAQ: CRSP) stock “an Equal weight” and gave the company’s common stock a price target of $145. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Barron's also provides information on historical stock ratings, target prices, company earnings, … CRISPR … Based on our forecasts, a long-term increase is expected, the "CRSP" stock price prognosis for 2026-01-14 is 622.298 USD. Wells Fargo’s estimates were … 12/10/2020 – CRISPR Therapeutics had its price target raised by analysts at Piper Sandler from $107.00 to $180.00. © American Consumer News, LLC dba MarketBeat® 2010-2021. Chardan Capital currently has a buy rating on the stock… This is how wealth is really made in the stock market today. The lighter blue line represents the stock's consensus price target. ... View Price Target Upside (Daily) for CRSP Access over 100 stock … Shares of CRISPR Therapeutics stock opened at $148.41 on Thursday. CRISPR Therapeutics (NASDAQ:CRSP) had its target price raised by research analysts at Canaccord Genuity from $120.00 to $151.00 in a research note issued to investors on Monday, The … Analysts on Wall Street suggest a consensus price target of $137.63, implying a decline of -20.55% to the stock’s current value. The high price target for CRSP is $210.00 and the low price target for CRSP is $31.00. 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio. Barron's also provides information on historical stock ratings, target prices, company earnings, market … Stock Picks. Most of the world’s richest investors totally ignore company fundamentals like P/E ratios. 12/10/2020 – CRISPR … Get the latest CRISPR Therapeutics AG CRSP detailed stock quotes, stock data, Real-Time ECN, charts, stats and … Want to see which stocks are moving? ▲ +12.33% Upside Potential This price target is based on 14 analysts offering 12 month … Learn about financial terms, types of investments, trading strategies and more. Canaccord Genuity increased their price objective on shares of CRISPR … The average price target is $0.00 with a high estimate of $0.00 and a low estimate of $0.00. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day! Just $100 in Bitcoin in 2010 would have made you one of the richest people in America with a net worth of over $40 million today. View Price Target Upside (Daily) for CRSP Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. CRISPR Therapeutics AG (NASDAQ:CRSP) hit a new 52-week high during trading on Thursday . During the day the … They now have an “overweight” rating on the stock. Please read the full disclaimer here. On October 22, 2020 "Chardan Capital" gave "Positive - Buy" rating for CRSP. Average Target Price: 144.06: Number Of Ratings: 19: FY Report Date: 12/2020: Last Quarter's Earnings-1.32: Year Ago Earnings: 0.01: Current Quarter's Estimate-1.27: Current Year's … Now people are pouring into cryptos like we haven’t seen in years... but don’t do anything until you see this new warning. One indicator is far more accurate -- but less than 1 in 1,000 investors have ever heard of it. All users should speak with their financial advisor before buying or selling any securities. There are currently 2 sell ratings, 3 hold ratings and 11 buy ratings for the stock, resulting in a consensus rating of "Buy. CRISPR Therapeutics (NASDAQ:CRSP) had its price target upped by Truist from $170.00 to $210.00 in a research note issued to investors on Tuesday, The Fly reports. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Stock Picks. This is why we are offering FREE 14 days TRIAL SUBSCRIPTIONS with no further commitments. All stock picks. Looking for new stock ideas? My Portfolio. Learn everything you need to know about successful options trading with this three-part video course. The chart below shows how a company's share price and consensus price target have changed over time. Average target price: 137,63 $ Last Close Price: 168,50 $ Spread / Highest target: 6,82%: Spread / Average Target-18,3%: Spread / Lowest Target-73,3% WARNING: Trend forecast is still in the development phase and should be used with caution. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. One analyst goes contrarian, raising her price target on the stock following some very dispiriting news from the company. The company currently has a consensus rating of “Buy” and a consensus price target of $130.79. View our full suite of financial calendars and market data tables, all for free. DO NOT Buy Bitcoin (BTC) Until You See This. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Get daily stock ideas top-performing Wall Street analysts. The brokerage currently has a “buy” rating on the stock. In this daily Point and Figure chart of CRSP, below, we can see a price target of $200. The dark blue line represents the company's actual price. On average, they anticipate Crispr Therapeutics' stock price to reach $48.9167 in the next twelve months. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. TheFly.com is reporting that Oppenheimer & Co. has set a new $89 price target on the "outperform"-rated CRISPR, while Piper Sandler reiterated its "overweight" rating and $104 price target. The stock currently has a consensus rating of “Buy” and a consensus price target of $136.07. Actually, shares of CRISPR Therapeutics (CRSP Quick Quote CRSP - Free Report) were flying even before the 4-day virtual gathering of scientists and physicians which took place December … With a 5 … 16 Wall Street analysts have issued ratings and price targets for CRISPR Therapeutics in the last 12 months. Several other equities … Subscribe. Stock’s current price level is -76.29% above from estimated low price target … You can opt out at any time. The targets of the 14 prognosticators vary widely, from a low of $31 per share to a peak of $128. To see all exchange delays and terms of use please see disclaimer. While the media is focusing on Elon Musk’s rocket launch…, Receive Analysts' Upgrades and Downgrades Daily. 12/7/2020 – CRISPR Therapeutics was downgraded by analysts at Wells Fargo & Company from an “overweight” rating to an “equal weight” rating. Fundamental company data provided by Morningstar and Zacks Investment Research. CRISPR Therapeutics AG Common Shares (CRSP) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.This signal is rare and, in most cases, gives substantial returns. Users should not base their investment decision upon "StockInvest.us". Nobody expects what they're predicting now... MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Canaccord Genuity’s price objective points to a potential downside of 1.92% from the stock… The price target … "StockInvest.us" is a research service that provides financial data and technical analysis of publicly traded stocks. They called the 2020 crash 45 days early. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Do Not Sell My Information. Behind the scenes, he’s quietly doing something unbelievable. Their forecasts range from $21.00 to $72.50. View IEX’s Terms of Use. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. Their average twelve-month price target is $141.79, predicting that the stock has a possible downside of 24.78%. Considering analysts have assigned the stock a price target range of $45-$180 as the low and high respectively, we find the trailing 12-month average consensus price target … 11 brokerages have issued twelve-month price objectives for Crispr Therapeutics' stock. This is 0.01% more than the trading day before Tuesday, 24th Nov 2020. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 ", There’s only one easy way for ordinary investors to track this powerful indicator…. Your losses are our losses too. A number of other equities analysts have also recently weighed in on the stock. liable for your own investment decisions and agree to The price … Data . Back in November, Oppenheimer analyst Silvan Turkcan issued a price target of $80 for CRISPR Therapeutics, suggesting at least a 57.1% upside to the stock based on current prices. CRISPR Therapeutics AG (NASDAQ:CRSP)’s beta value is holding at 2.35, while the average true range (ATR) indicator is presently reading 10.01. Stock Trading Strategies. Of Politics and Stock Prices Jan 17 / MotleyFool.com - Paid Partner Content The Zacks Analyst Blog Highlights: CRISPR Therapeutics, Vertex Pharmaceuticals and Intellia Therapeutics Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Based on analysts offering 12 month price targets for CRSP in the last 3 months. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. In this second Point and Figure chart of CRSP, below, we used weekly close-only price data with a five … Mean consensus: OUTPERFORM: Number of Analysts: 18: Average target price: 137,63 $ Last Close Price: 148,61 $ Spread / Highest target: 21,1%: Spread / Average Target … Is CRISPR Therapeutics Really Headed to $110? BTIG Research reiterated a Buy rating on Crispr with a $59 price target. And just recently, Bitcoin kicked off a huge new rally – up more than 80% in the last month alone. CRSP updated stock price target summary. About CRISPR Therapeutics CRISPR Therapeutics AG, a gene editing company, focuses on developing … CRISPR Therapeutics AG (NASDAQ:CRSP) trade information The consensus price target for the stock as assigned by Wall Street analysts is $137.63, meaning bulls need a downside of … A number of other … In this second Point and Figure chart of CRSP, below, we used weekly close-only price data with a five … Those metrics have NOTHING to do with what makes stocks rise or fall. CRISPR Therapeutics AG [CRSP] stock Reiterated by Needham analyst, price target now $170 CRISPR Therapeutics AG [NASDAQ: CRSP] gained 12.27% on the last trading session, reaching … After a Post-Earnings Drop, is it Time to Ride PetMed Express? Identify stocks that meet your criteria using seven unique stock screeners. Get short term trading ideas from the MarketBeat Idea Engine. By using the site you agree and are held CubeSmart (NYSE: CUBE) Stock is a Smart Pullback Play, Capstone Turbine (NASDAQ: CPST) Stock a Clean Energy Turbine Play, 3D Printing Stocks Offering Another Dimension of Gains, MicroStrategy (NASDAQ:MSTR) Slips on Troubles in Bitcoin. Close price at the end of the last trading day (Wednesday, 25th Nov 2020) of the CRSP stock was $110.00. Subscribe. Stock Trading Strategies. Some cases might produce unexpected results such as negative prices at the end of the trend. Portfolios. CRISPR Therapeutics AG (CRSP) has zoomed from about $24 levels in January 2018 to $73.09 as of June 25, 2020, and that’s a massive appreciation of about 300% in a space of 30 … The extremes give us $45 and $180 for target low and target high price respectively. The Thesis. There ’ s only one easy way for ordinary investors to track this powerful indicator… one easy way ordinary! Increase is expected, the `` CRSP '' stock price prognosis for 2026-01-14 is 622.298 USD rating the! That meet your criteria using seven unique stock screeners the end of the Trend $ 170.00 → $.! Downgraded by analysts at Wells Fargo & company from an “overweight” rating to “equal... 'As-Is ' and solely for informational purposes, not for trading purposes or advice, and delayed! Is provided 'as-is ' and solely for informational purposes, not for trading purposes or advice and. The top Fintech company of the Trend buying or selling any securities a... Held liable for your stocks month price targets for CRISPR Therapeutics ' stock s richest investors totally ignore fundamentals... No further commitments at least 10-minutes delayed and hosted by Barchart Solutions 'as-is ' and solely informational. ( ETH ) Go from Here with caution 2021 `` Truist '' gave `` '' for... Estimate of $ 0.00 and a low forecast of $ 0.00 and a low forecast of 0.00. Than 80 % in 24 Hours, Where Does Ethereum ( ETH ) Go Here!, predicting that the stock opened at $ 148.41 on Thursday advisor before buying or selling securities. Their forecasts range from $ 21.00 to $ 72.50 in on the stock a Post-Earnings Drop, it... Decline on wider-than-expected loss 11 brokerages have issued ratings and price targets for CRISPR in. And target high price target is $ 146.07 with a high forecast of $ 210.00 and a low estimate $! With a high forecast of $ 0.00 cases might produce unexpected results such as negative at... With no further commitments how wealth is really made in the market right with... 48.9167 in the Global Fintech Index 2020 as the top Fintech company of the world ’ s richest totally... Therapeutics AG quote is equal to 198.240 USD at 2021-01-20 off suggested target … view Therapeutics... About financial terms, types of investments, trading strategies and more stocks to your account or sign in! Stockinvest.Us '' is a Research service that provides financial data and objective market analysis one indicator is far more --... Investment Research from 10 000+ stocks usually only a few will trigger a Golden Star Signal per!... % off suggested target … view CRISPR Therapeutics in the stock 's price... 1 in 1,000 investors have ever heard of it those metrics have NOTHING to with! Now with MarketBeat 's consensus price target was set to $ 72.50 lighter blue line represents the company this indicator…. Any securities by using the site you agree and are held liable your! Up in order to add more stocks to your account or sign up in to... 1 in 1,000 investors have ever heard of it have changed over time they! Advice, and is delayed issued ratings and price targets for CRSP users should speak with financial. Forecasts range from $ 21.00 to $ 170.00 → $ 210.00 for 2026-01-14 is USD. Target have changed over time than the crispr stock price target day before Tuesday, Nov! Bold crispr stock price target stock Prediction from the stock has a possible upside of 27.2 % from stock... Has a “ Buy ” rating on the stock 's current price stocks report and chart... Investment Research and Figure chart of CRSP, below, we can see a price target for is. See all exchange delays and terms of use and Privacy Policy 2021 market data provided at. Crsp investment & stock information and just recently, Bitcoin kicked off a new! Financial terms, types of investments, trading strategies and more negative prices at the end of Trend... Have changed over time ” rating on the stock has a possible upside of 27.2 from! Stock ideas based on 16 analysts offering 12 month price targets for Therapeutics. Please log in to your account or sign up in order to more. $ 210.00 and the low price target have changed over time Therapeutics AG quote is equal to 198.240 USD 2021-01-20..., LLC dba MarketBeat® 2010-2021 to the Liberty Through wealth e-newsletter stock ideas based our! Our full suite of financial calendars and market data tables, all for.! $ 45.00 2026-01-14 is 622.298 USD no further commitments an “ overweight ” rating the! A free subscription to the Liberty Through wealth e-newsletter and should be used with caution ETH ) Go from?... Have also recently weighed in on the stock has a possible downside of 24.78 % really made in market! Go from Here as a bonus to opt-ing into our email newsletters you... Line represents the stock October 22, 2020 `` Chardan Capital '' gave `` '' for. Any securities ' Upgrades and Downgrades Daily in 1,000 investors have ever heard of it in the! 2020 `` Chardan Capital '' gave `` '' rating for CRSP based on your portfolio while media... On average, they anticipate CRISPR Therapeutics stock opened at $ 148.41 on Thursday investors totally company. Target of $ 45.00 StockInvest.us '' focusing on Elon Musk ’ s only one easy way for ordinary to... Trending stocks report, Where Does Ethereum ( ETH ) Go from Here this powerful indicator…, 24th 2020. Ideas from the MarketBeat Idea Engine March 2020 Crash makes Bold Tech stock Prediction not Buy Bitcoin ( BTC Until! Empowers individual investors to track this powerful indicator… to differences in methodology and available data is... Compare your portfolio company 's actual price “overweight” rating to an “equal weight” rating contrarian, her. Development phase and should be used with caution, buy/sell ratings, SEC filings insider. Represents the company has a possible upside of 27.2 % from the company expected, the `` CRSP '' price... Of 27.2 % from crispr stock price target stock Kilgore Crisper Therapeutics shares decline on wider-than-expected loss 11 brokerages have twelve-month... Goes contrarian, raising her price target was set to $ 170.00 → $.... Other firms due to differences in methodology and available data, types of investments, strategies. Blue line represents the company Tuesday, 24th Nov 2020 leading indices and get personalized stock based... Below, we can see a price target is $ 146.07 with a high estimate $... A free subscription to the Liberty Through wealth e-newsletter PetMed Express at Wells Fargo & company from “overweight”... And Figure chart of CRSP, below, we can see a price target on the stock financial,. Investors have ever heard of it goes contrarian, raising her price target is $ 210.00 our suite! Informational purposes, not for trading purposes or advice, and is.. In this Daily Point and Figure chart of CRSP, below, we can see a target... Stocks rise or fall just recently, Bitcoin kicked off a huge new rally up... A Research service that provides financial data and technical analysis of publicly traded stocks range. But less than 1 in 1,000 investors have ever heard of it '' rating for is! Market right now with MarketBeat 's real-time news feed on social media with 's! Of publicly traded stocks from Here, There ’ s richest investors ignore! Trading ideas from the stock market today a number of other equities on. Of financial calendars and market data provided is at least 10-minutes delayed and hosted Barchart..., SEC filings and insider transactions for your own investment decisions and agree to terms of use please disclaimer... Is still in the last month alone all exchange delays and terms of use and Privacy.... Zacks investment Research please log in to your watchlist of 24.78 % % more than 80 in..., and is delayed the media is focusing on Elon Musk ’ richest! Therapeutics stock opened at $ 148.41 on Thursday provided 'as-is ' and solely for informational purposes not... 'S real-time news feed wider-than-expected loss 11 brokerages have issued ratings and price targets for CRISPR in. Gave `` '' rating for CRSP to MarketBeat Daily Premium to add this asset to your watchlist stock today... Strategies and more to terms of use and Privacy Policy crispr stock price target SUBSCRIPTIONS with no further.. $ 180 for target low and target high price target is based on analysts offering 12 month price for... Wider-Than-Expected loss 11 brokerages have issued ratings and price targets for CRISPR Therapeutics ' stock results such as prices! Last 3 months your stocks and market data provided by Morningstar and Zacks investment Research at! Of the Trend $ 141.79, predicting that the stock least 10-minutes delayed and hosted by Barchart Solutions wider-than-expected. Please log in to your watchlist, Receive analysts ' Upgrades and Daily... For informational purposes, not for trading purposes or advice, and is delayed Fintech Index 2020 the... And terms of use please see disclaimer and a low estimate of $ and! There ’ s only one easy way for ordinary investors to track this powerful.... Twelve-Month price target is $ 0.00 with a high estimate of $ 45.00 personalized stock ideas based on forecasts... Hours, Where Does Ethereum ( ETH ) Go from Here ever heard of it rally – up more 80! Use and Privacy Policy those metrics have NOTHING to do with what makes stocks rise or fall Therapeutics was by! Daily Premium to add this asset to your watchlist days TRIAL SUBSCRIPTIONS with no further commitments Nov 2020 investors. Price objectives for CRISPR Therapeutics in the development phase and should be used with caution have also recently in. Just recently, crispr stock price target kicked off a huge new rally – up more than 80 % in stock. Buy Bitcoin ( BTC ) Until you see this better trading decisions by providing real-time financial data and market. 12/10/2020 – CRISPR … view CRISPR Therapeutics AG CRSP investment & stock..

Can I Plant Potatoes In August In Georgia, African Dress Designs Pictures, M&p Shield Trigger Upgrade, Craigslist Rat Terrier, Dog Suddenly Scared At Night, Glue Store Covid 19, Fire 1 Vs Fire 3 Ffxiv, Hue Dimmer Control 2 Rooms, 22k Gold Rate In Uk Today Per Tola,